Is ESALY or DVY a better dividend investment in 2026?

ESALY currently yields 31.26% with a 5% 5-year dividend growth rate. DVY yields 3.50% with 5% growth. The better choice depends on your goal: ESALY offers higher current income.

What is the dividend yield difference between ESALY and DVY?

ESALY has a forward dividend yield of 31.26% ($19.23/share annually). DVY yields 3.50% ($5.25/share annually). The yield gap is 27.76 percentage points.

Home › Compare › ESALY vs DVY

ESALY vs DVY: Dividend Comparison 2026

ESALY yields 31.26% · DVY yields 3.50%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ESALY wins by $273.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

ESALY

● Live price

31.26%

Share price

$61.51

Annual div

$19.23

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$298.7K

Annual income

$71,135.45

Full ESALY calculator →

DVY

● Live price

3.50%

Share price

$150.03

Annual div

$5.25

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.1K

Annual income

$437.78

Full DVY calculator →

Portfolio growth — ESALY vs DVY

📍 ESALY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ESALY	DVY
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ESALY + DVY cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ESALY pays

DVY pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ESALY

Annual income on $10K today (after 15% tax)

$2,657.23/yr

After 10yr DRIP, annual income (after tax)

$60,465.13/yr

DVY

Annual income on $10K today (after 15% tax)

$297.17/yr

After 10yr DRIP, annual income (after tax)

$372.11/yr

At 15% tax rate, ESALY beats the other by $60,093.02/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ESALY + DVY for your $10,000?

ESALY: 50%DVY: 50%

100% DVY50/50100% ESALY

Portfolio after 10yr

$161.9K

Annual income

$35,786.61/yr

Blended yield

22.11%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ESALY buys

DVY buys

No recent congressional trades found for ESALY or DVY in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricESALYDVY

Forward yield	31.26% ✓	3.50%
Annual dividend / share	$19.23 ✓	$5.25
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	7% ✓	0%
Portfolio after 10y	$298.7K ✓	$25.1K
Annual income after 10y	$71,135.45 ✓	$437.78
Total dividends collected	$238.7K ✓	$4.0K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ESALY vs DVY ($10,000, DRIP)

Year	ESALY Portfolio	ESALY Income/yr	DVY Portfolio	DVY Income/yr	Gap
1← crossover	$14,045	$3,344.99	$11,050	$349.62	+$3.0K → ESALY
2	$19,726	$4,698.03	$12,184	$361.04	+$7.5K → ESALY
3	$27,705	$6,598.37	$13,409	$372.07	+$14.3K → ESALY
4	$38,912	$9,267.41	$14,730	$382.68	+$24.2K → ESALY
5	$54,652	$13,016.06	$16,154	$392.89	+$38.5K → ESALY
6	$76,759	$18,281.04	$17,688	$402.69	+$59.1K → ESALY
7	$107,808	$25,675.69	$19,338	$412.07	+$88.5K → ESALY
8	$151,416	$36,061.47	$21,113	$421.04	+$130.3K → ESALY
9	$212,663	$50,648.29	$23,020	$429.61	+$189.6K → ESALY
10	$298,685	$71,135.45	$25,070	$437.78	+$273.6K → ESALY

ESALY vs DVY: Complete Analysis 2026

ESALY — Stock

Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.

Full ESALY Calculator →

DVY — ETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →

📬

Get this ESALY vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ESALY vs SCHD ESALY vs JEPI ESALY vs O ESALY vs KO ESALY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.